Hitachi forms nuclear medicine division
Japanese vendor Hitachi Medical of Tokyo has formed a new nuclearmedicine division to handle direct sales in North America of itsgamma cameras. The move culminates Hitachi's comeback in the modality,which began when Summit Nuclear stopped marketing the
Japanese vendor Hitachi Medical of Tokyo has formed a new nuclearmedicine division to handle direct sales in North America of itsgamma cameras. The move culminates Hitachi's comeback in the modality,which began when Summit Nuclear stopped marketing the Hitachiproducts following the merger of Summit and Sopha Medical (SCAN10/11/95).
Hitachi's Nuclear Medicine Products Division will be based inTwinsburg, OH, and will be a subsidiary of Hitachi Medical Corporationof America, which is based in Tarrytown, NY. Former Summit executiveGary Enos is general manager of the division.
At last month's Radiological Society of North America meeting,Hitachi displayed SpectraDigital V250 DSP, the company's variable-angledual-head gamma camera. The company also had panels on 511-keVcollimation and a work-in-progress Coincidence Detection Reconstruction(CDR) technique.
Hitachi is also developing a new nuclear medicine workstation,SpectraDigital 300SS, which is based on a Hewlett-Packard platformwith applications software developed in cooperation with MedasysDigital Systems. The computer is expected to be available earlythis year.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
